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Abstract Partial Least Squares-Discriminant Analysis
(PLS-DA) is a PLS regression method with a special binary
‘dummy’ y-variable and it is commonly used for classiﬁ-
cation purposes and biomarker selection in metabolomics
studies. Several statistical approaches are currently in use
to validate outcomes of PLS-DA analyses e.g. double cross
validation procedures or permutation testing. However,
there is a great inconsistency in the optimization and the
assessment of performance of PLS-DA models due to
many different diagnostic statistics currently employed in
metabolomics data analyses. In this paper, properties of
four diagnostic statistics of PLS-DA, namely the number of
misclassiﬁcations (NMC), the Area Under the Receiver
Operating Characteristic (AUROC), Q
2 and Discriminant
Q
2 (DQ
2) are discussed. All four diagnostic statistics are
used in the optimization and the performance assessment of
PLS-DA models of three different-size metabolomics data
sets obtained with two different types of analytical plat-
forms and with different levels of known differences
between two groups: control and case groups. Statistical
signiﬁcance of obtained PLS-DA models was evaluated
with permutation testing. PLS-DA models obtained with
NMC and AUROC are more powerful in detecting very
small differences between groups than models obtained
with Q
2 and Discriminant Q
2 (DQ
2). Reproducibility of
obtained PLS-DA models outcomes, models complexity
and permutation test distributions are also investigated to
explain this phenomenon. DQ
2 and Q
2 (in contrary to NMC
and AUROC) prefer PLS-DA models with lower com-
plexity and require higher number of permutation tests and
submodels to accurately estimate statistical signiﬁcance of
the model performance. NMC and AUROC seem more
efﬁcient and more reliable diagnostic statistics and should
be recommended in two group discrimination metabolomic
studies.
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1 Introduction
The goal of systems biology is to explore the interaction
between various components in a biological system. Met-
abolomics measurements provide quantitative information
on the metabolic level of the system. This metabolic level
has proven an important area of systems biology with the
aim to pinpoint putative metabolites related to disease,
genetic variation or nutritional interventions (Weckwerth
et al. 2004; Yang et al. 2004; Kind et al. 2007; van Velzen
et al. 2008; Bernini et al. 2009).
In metabolomics studies different analytical platforms
are often used to provide information on large groups of
metabolites. Most metabolomics studies result in complex
multivariate datasets with varying correlations between the
measured metabolite levels so that multivariate data anal-
ysis methods are needed to explore these complex datasets.
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discrimination models between two classes of subjects/
samples are used. One of the most used methods is Partial
Least Squares-Discriminant Analysis (PLS-DA) (Barker
and Rayens 2003; van Velzen et al. 2008). If a statistically
signiﬁcant discrimination between two classes e.g. the
cases and controls classes can be found, then the model
parameters can be interpreted for their discriminating
power and metabolic biomarkers can be found. In PLS-DA
models, a relationship between the metabolomics data and
the categorical variable y is developed in such a way that
categorical variable values can be predicted for samples of
unknown origin given the metabolomics data. Here, the
categorical variable y is a vector which values indicate
class membership of each sample included in the study e.g.
a vector with values of -1 and 1 where -1 represents each
sample belonging to the class of controls and 1 represents
each sample belonging to the class of cases. However, due
to the properties of regression models, the prediction y ˆi of
the i-th element of y can take any value, not necessarily
exactly -1 or 1. Translation of these values of y ˆ to class
membership (classiﬁcation procedure) is a critical point of
PLS-DA analysis and can be done, e.g. by applying a
threshold above which the sample will be assigned to the
cases class and below to the control class.
Another challenge of PLS-DA analysis is the accurate
estimation of the quality of the obtained models and
thereby differences between two classes. Many diagnostic
statistics have been introduced over the time to convert
values of y ˆ obtained for all the study samples into a single
number representing the overall quality of the discrimina-
tion model. In this paper we investigate the performance of
the four different diagnostic statistics which are usually
used for this purpose in metabolomics when PLS-DA is
applied. They are: the number of misclassiﬁcations (NMC),
the Area Under the Receiver Operating Characteristics
(AUROC), Q
2 and Discriminant Q
2 (DQ
2). The natures of
these diagnostic statistics are very different. Whereas the
Q
2/DQ
2 are derived directly from the (ratio-scaled) model
predictions y ˆ of y, the NMC/AUROC are derived from the
(nominal-scaled) class memberships translated from y ˆ.I ti s
debatable which measurement scale should be used for
diagnostic statistic of PLS-DA (Stevens 1946).
The power of each of diagnostic statistics is investigated
in terms of its ability to provide a statistically signiﬁcant
measure of the discrimination between two classes of
subjects (e.g. the cases and the controls) when known
multivariate effects of different magnitudes are present in
the data. This is accomplished by superimposing known
multivariate effects of increasing magnitude on the meta-
bolic proﬁles of subjects from the cases class and calcu-
lating the PLS-DA models: one PLS-DA model per each
data set with different magnitude of superimposed effect
and diagnostic statistics used. In order to obtain unbiased
estimates of model performance, PLS-DA is applied in a
double cross validation scheme. This means that the four
diagnostic statistics are used not only to assess the ﬁnal
quality of the PLS-DA models but also for the optimization
of the model, e.g. to select the optimal complexity of model
(optimal number of latent variables, #LV). Statistical sig-
niﬁcance of each PLS-DA model is estimated by compar-
ing the value of the diagnostic statistics (Q
2, DQ
2, NMC or
AUROC) to values of its null reference distribution H0
obtained by permutation tests.
Datasets obtained by two different analytical platforms
commonly used in the metabolomics studies: UPLC-MS
and NMR were used to evaluate properties of the four
diagnostic statistics. The multivariate effects superimposed
into data sets were intended to represent two situations that
can occur in real life metabolomics data analysis: investi-
gating a nutritional effect (in the case of the UPLC-MS
data set) and investigating an effect of exposure to a
chemical pollutant (in the case of the NMR data set).
Moreover, datasets of different size were used to draw
general conclusions independent of data set size.
2 Theory
2.1 PLS-DA modeling with a double-cross validation
scheme
2.1.1 PLS-DA
Partial least squares discriminant analysis (PLS-DA) and
its extensions like multilevel PLS-DA (MPLS-DA, (van
Velzen et al. 2008)) and orthogonal PLS-DA (OPLS-DA,
(Trygg and Wold 2002)) are the most used classiﬁcation
methods in metabolomics. PLS-DA consists of a classical
PLS regression where the dependent variable y is cate-
gorical and represents samples class membership e.g. y can
be a vector with values of -1 and 1 where -1 represents
each sample belonging to the class of controls and 1 rep-
resents each sample belonging to the class of cases (Barker
and Rayens 2003). By making use of class information,
PLS-DA tends to improve the separation between the (two)
groups of samples.
2.1.2 PLS-DA with double cross validation schema
Two steps are critical when building a PLS-DA model: the
selection of the optimal model complexity e.g. optimal
number of latent variables (#LV) and the assessment of the
overall quality of the model. In the PLS-DA context, the
#LV needs to be optimized in such a way that a suitable
number of latent variables is used to build the model.
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thus the best discrimination between samples from two
different classes.
Model optimization (i.e. selection of the optimal #LV)
and model quality assessment should be always carried out
in a double cross validation schema because then assess-
ment of model quality and the model optimization are
independent. Samples which are used in ﬁnal model
assessment are not used in the model optimization (cali-
bration): moreover the calibration of the model is carried
on in a similar unbiased way (Smit et al. 2007; Westerhuis
et al. 2008).
A double cross validation scheme consists of two nested
loops CV1 and CV2, (see Smit et al. 2007). The aim of
CV1 is to optimize complexity of the PLS-DA model and
the aim of CV2 is to assess ﬁnal model performance. In the
outer loop (CV2) the complete dataset is split into a test set
and a rest set: the test set is set aside and the rest set is used
in a single cross validation (inner loop, CV1). In the CV1
the rest set is again split into a validation (sometimes called
optimization) set and a training set. Then, training set is
used to develop a series of PLS-DA models with 1 to n
latent variables (#LVs) and these PLS-DA models are used
to calculate a series of y ˆin for validation set samples which
is further used in the selection of an optimal #LV (Fig. 1a).
The selection depends on the values of the diagnostics
statistics used: #LV with the highest values of AUROC, Q
2
and DQ
2 and the lowest values of NMC are selected. The
CV1 procedure is repeated until all samples from rest set
have been in the validation set once and only once. For
each rest set a separate PLS-DA model with optimal #LV is
obtained and this model is further used in CV2 loop to
predict y ˆi for each test set sample. The CV2 procedure is
repeated until each sample has been in test set once and
only once. On the basis of the y ˆi obtained for all the
samples vector y ˆ is obtained and used in assessment of the
overall PLS-DA model quality (see Fig. 1b).
Training, validation and test sets (in both CV1 and CV2
loops) are deﬁned by partitioning the samples in k disjoint
subsets. In this study, k = 8 was chosen for the outer loop
Fig. 1 Graphical illustration of use of diagnostic statistics: NMC,
AUROC, Q
2 and DQ
2 in double cross validation procedure of PLS-
DA. a Use of diagnostics statistics in selection of optimal number of
latent variables in CV1, b use of diagnostics statistics in assessment of
overall PLS-DA model quality after double cross validation procedure
(CV2)
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commonly used partition in double cross validation pro-
cedure applied to metabolomic data sets. Samples of both
classes were always represented in a 1:1 ratio in test, val-
idation and training sets.
As many different disjoint partitions of a data set are
possible, the overall procedure was repeated M times (30 in
the case of the UPLC-MS dataset and 20 in the case of the
NMR data set) resulting in M submodels. That gives
M repetitions of the y ˆ vector: y ˆ1,…, y ˆM. (Fig. 1b). This
procedure enables to track the reproducibility of the PLS-
DA output (see Sect. 4.2.3). The ﬁnal measures of quality
are given as average values over the M values of chosen
diagnostics statistics. The choice of an 8:7 data split and
M = 30 (20) is a tradeoff between accuracy and compu-
tational time.
2.2 Diagnostic statistics
2.2.1 The Q
2 statistic
The Q
2 is de facto the default diagnostic statistic to validate
PLS-DA models in metabolomics included in commercial
or academic statistical packages like SIMCA (Umetrics
Inc, Kinnelon NJ), the PLS-toolbox for Matlab (Eigen-
vector Research Inc, Wenatchee WA), SAS (SAS Institute
Inc, Cary NC) or Metaboanalyst (Xia et al. 2009).
The Q
2 is based on the evaluation of the error between
the predicted categorical variable y ˆ and the known y. The
prediction error is summed over all the samples (PRESS)
and referred to the total sum of squares (TSS) (Cruciani
et al. 1992):
PRESS ¼
X
i
ðyi   ^ yiÞ
2 ð1Þ
TSS ¼
X
i
ðyi     yiÞ
2 ð2Þ
Q
2 is then deﬁned as:
Q2 ¼ 1  
PRESS
TSS
ð3Þ
In a PLS regression the values of y ˆi are not bounded in
the range [-1, ?1] but, in principle, can assume any value
in the range [-?, ??]. Any deviation of y ˆi from yi
contributes to the PRESS: for instance, a prediction of
y ˆi =- 2 for a sample with yi =- 1 will result in a
contribution of 1
2 to the PRESS even if this corresponds to
a correct classiﬁcation when the discrimination border is
set at y ˆi = 0. The same happens if a prediction of 0 (y ˆi = 0)
is given to this sample, then the contribution to the PRESS
is still 1 = (-1)
2. This drawback is (partially) overcome
by the so called Discriminant Q
2 (DQ
2).
2.2.2 Discriminant Q
2 statistics, DQ
2
Discriminant Q
2, DQ
2 (Westerhuis et al. 2008), is based on
the fact that the prediction error is disregarded when the
prediction is beyond the class label (i.e. [1o r\-1).
PRESS is then redeﬁned as PRESSD:
PRESSD ¼
X
 1\^ yi\þ1
ðyi   ^ yiÞ
2 ð4Þ
and the deﬁnition of DQ
2 straightforwardly follow from
(3):
DQ2 ¼ 1  
PRESSD
TSS
ð5Þ
This correction is effective only when the prediction is
in the direction of the true class label, for instance when a
sample with yi =- 1 is predicted to be y ˆi =- 1.5. If this
sample is predicted with y ˆi = 0o r?1, the prediction error
contributes to the PRESSD. It is then clear that the larger
the prediction error, the larger the PRESSD which in turn
implies a smaller value of DQ
2.
2.2.3 Number of misclassiﬁcations (NMC)
In the PLS-DA predicted values of y ˆi can be transformed
into a class membership (i.e. cases/controls) by relating
them to a set discrimination threshold (classiﬁcation
boundary). This threshold is usually set at 0 when two
classes have similar size and variance and when y is a
vector of -1 (for samples from class of controls) and 1 (for
samples from class of cases). If these conditions are not
met the discriminative threshold can be adjusted to other
values (Lloyd et al. 2009). The predicted values y ˆi for the
i-th sample is related to the 0 threshold: the sample is
assigned to class of cases if y ˆi C 0 or to class of controls if
y ˆi\0. The assigned class is then compared with the true
class membership and classiﬁed either as a True Positive
(TP), a True Negative (TN), a False Positive (FP) or a False
Negative (FN). When all samples have been predicted and
assigned to a class, the total number of True Negatives,
False Positives, False Negatives, and True Positives can be
computed to create a Confusion Matrix (Broadhurst and
Kell 2006) (see also Supplementary Fig. 1) which sum-
marizes the prediction ability of the model.
The number of misclassiﬁcation (NMC) is calculated as
the sum of False Positive and False Negative:
NMC ¼ FP þ FN
The NMC is the most intuitive of all diagnostic statistics
as it simply indicates the number of samples which are
wrongly classiﬁed by the model.
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Apart from the NMC, several criteria can be derived from
the confusion matrix (Lloyd et al. 2009) and the speciﬁcity
(Sp) and the sensitivity (Se) (Altman and Bland 1994) are
two of the mostly used, especially in assessing the per-
formance of diagnostic tests.
The speciﬁcity and the sensitivity are deﬁned as
Sp ¼
TN
TN þ FP
ð6Þ
Se ¼
TP
TP þ FN
ð7Þ
The sensitivity is a measure of how well the model is
able to correctly classify samples of the class of cases,
while the speciﬁcity measures how well the model can
predict samples from the class of controls. The Receiver
Operator Characteristic (ROC) (Fawcett 2004; Davis and
Goadrich 2006) combines these two parameters. By
plotting the sensitivity against 1-speciﬁcity for different
values of the discrimination threshold a ROC curve can be
deﬁned. The ROC curve provides a spectrum of
performance assessments and the area under the ROC
(AUROC) is commonly used as diagnostic statistics of
PLS-DA models. The AUROC values range from 1 (perfect
discrimination between classes) and 0 (0.5 and lower
usually means no discrimination at all).
2.2.5 Differences between NMC/AUROC and Q
2/DQ
2
Class membership can be coded as 1 and -1 in categorical
variable y: a sample belongs either to class 1 (e.g. cases) or
-1 (e.g. controls). These classes could also have been
indicated by class A and B showing that the numerical
values 1 and -1 are irrelevant (they are only used as
dummy variables). Predicted class memberships (y ˆ) are
also categorical variables and the NMC/AUROC statistics
are directly derived from these memberships and are so-
called permissible statistics (Stevens 1946). For instance,
the interpretation of means and variances are problematic
for categorical variables while they are well-deﬁned for
ratio-scaled variables.
The Q
2 and Discriminant Q
2 are derived from predic-
tions (y ˆi) and are allowable statistics if we assume that the
y ˆi values are ratio-scaled variables. It is interesting to note
that the deﬁnition of Q
2 and DQ
2 relies on the calculation
of the mean of the categorical vector y (Eq. 2), a statistic
which is not permissible for categorical variables (Stevens
1946). This is a fundamental problem of using these sta-
tistics in the PLS-DA.
Errors in the class membership predictions (i.e. devia-
tions from the values -1/?1) have a different impact on
the behavior of the four diagnostic statistics Q
2, DQ
2, NMC
and AUROC. This can be shown by means of a simple
simulation. We simulated the prediction
^ y ¼
 1
 1
 1
1
1
1 þ e
0
B B B B B B @
1
C C C C C C A
of a vector
y ¼
 1
 1
 1
1
1
1
0
B B B B B B @
1
C C C C C C A
containing the class memberships of six samples. A plot of
the four diagnostic statistics as a function of the error e on
the prediction of the ﬁrst sample is shown in Fig. 2. The
error e ranges from -10 to 10 with e = 0 corresponding to
a perfect prediction, and an increment of 0.25. A value of 0
was used as the discrimination threshold in the simulation.
This means that if the prediction (1 ? e) of a sample of
class 1 is B 0, the sample is wrongly classiﬁed.
It appears that NMC and AUROC are not sensitive to the
magnitude of the error e while Q
2 and DQ
2 strongly depend
on the magnitude e. For example an error e = 6 gives a
lower Q
2 than an error e = 2 where NMC is equal to 1 for
both errors. Values of Q
2 (and DQ
2) are sensitive to out-
liers with high errors e.
2.2.6 Permutation test
Although an NMC = 0o raQ
2 = 0.99 can be thought to
correspond to good models with a high discriminating
power, these values of the diagnostic statistics can be
attained purely by chance due to a lucky random choice of
samples in the test, validation and training sets. This means
that it is not known which value of these diagnostic sta-
tistics really corresponds to a good discrimination between
groups (Westerhuis et al. 2008). To overcome these prob-
lems and to give a measure of the statistical signiﬁcance of
the diagnostic statistics (P-value), a permutation test was
introduced (Lindgren et al. 1996; Golland et al. 2005;
Mielke and Berry 2007; Pesarin and Salmaso 2010). Per-
mutation tests assume that there is no difference among
two groups that are randomly formed (Westerhuis et al.
2008). In a permutation test the labels of the samples are
randomly permuted and a new classiﬁcation model is cal-
culated (Lindgren et al. 1996). The performance of the
model obtained with is assessed by one of the four diag-
nostic statistics and the values of diagnostic statistics are
Diagnostic statistics for PLS-DA models S7
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for NMC and lower for Q
2, DQ
2 and AUROC. By repeating
this procedure N times, a null distribution of H0 for each of
four diagnostic statistic is obtained. H0 is then a distribu-
tion of diagnostic statistics of models that are expected to
be insigniﬁcant (Fisher 1937).
Statistical signiﬁcance of the PLS-DA model is then
assessed by relating the values of the diagnostic statistics
for this model calculated with the original data set to the H0
distribution of the diagnostic statistics values obtained for
models calculated with the permuted data sets. In case of
NMC the upper threshold P for the P-value is calculated as
P ¼
1 þ #ðNMCp  NMCÞ
N
ð7Þ
where #(NMCp B NMC) is the number of element in the
null distribution which are smaller or equal to the NMC for
the original data set. It is worthy to note that the estimation
of P depends, apart N, on the value of NMC which is
actually estimated by averaging the M values obtained by
M different submodels (Fig. 1b), that is P is also sensitive
to the distribution of the values of NMC. In the case of
AUROC, Q
2 and DQ
2, P is calculated with a similar for-
mula but inequality B must be replaced with C and similar
considerations do apply.
When using the permutation distribution to infer P-
values, the left tail (in the case of NMC) and right tail (in
the case of of Q
2, DQ
2 and AUROC) are of interest. This
means that the number of permutations needs to be ‘‘large
enough’’ to sample the tails of the distribution. The lower
limit of the number of permutations is dictated by the
required statistical signiﬁcance: for instance, to attain a P-
value \0.01 at least 100 permutations are necessary but
cannot be sufﬁcient to a proper sampling of the distribu-
tions tails. An optimal number is difﬁcult to be inferred:
(Churchill and Doerge 1994) suggested that to estimate a
permutation P-value of 0.01 as many as 10
4 permutations
are needed in genetics applications. The true permutation
P-value can be calculated by taking into account all the
possible permutations (Sun and Wright 2010) which is
actually dictated by the number of samples: with N sam-
ples, N! are permutations possible. With N = 60 (the size
of a typical small metabolomics dataset) there are [10
80
possible permuted data sets that obviously cannot all be
screened. On the other hand, a limited number of samples
can hamper the sampling of the tails because extreme
values of the distribution may not be detected. This issue is
discussed further in Sect. 4.1.
3 Materials and methods
3.1 Data sets
3.1.1 UPLC-MS data set
The UPLC-MS data set consists of 96 samples 9 101 lipids
levels measured at the Demonstration and Competence
Fig. 2 Behavior of the diagnostic statistics NMC, AUROC, Q
2 and DQ
2 as a function of the error e on the simulated prediction y ˆ = [-1 -1 -11
11? e] of a vector y = [-1 -1 -1 1 1 1] containing the class membership of six samples
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University, Leiden, The Netherlands. Technical details of
the UPLC-MS lipidomics platform are described in (Hu,
van Dommelen et al. 2008) and in the Supplementary
Material. 96 samples are serum samples collected from
healthy subjects before the start of the nutritional inter-
vention study in the frame of BCL study (more information
available on request). To 48 randomly selected samples
nutritional effects were added as described in Sect. 3.1.3.
3.1.2 NMR data set
Ten different data sets, each consisting of 60 NMR spectra
(small NMR data sets), have been constructed by randomly
selecting the spectra from a pool of 256 homogenous NMR
serum spectra of subjects of the DiOGenes study (Larsen
et al. 2009). Technical details of
1H NMR spectra acqui-
sition are presented in the Supplementary Material. Each
small NMR dataset was composed of 60 spectra (samples)
each with 420 data points. A multivariate effect has been
subsequently added to the 30 spectra randomly selected
from 60 spectra (the case group). Using the same strategy,
ten larger NMR data sets (large NMR data sets), consisting
of 200 NMR spectra (100 ? 100) have also been
generated.
3.1.3 Superimposed multivariate effects
3.1.3.1 Nutritional effects Original multivariate nutri-
tional effects were changes in levels of 101 lipids calcu-
lated for each of 33 healthy subjects participating in the
nutritional study (group of 33 subjects with the largest
nutritional effect in BCL study). For each of the 33 subjects
changes between lipid levels before and after nutritional
intervention were calculated. On that basis 33 different
original multivariate nutritional effects were derived. Ten
different magnitudes of these effects were obtained by
multiplication of the original effects by constant numbers:
1 (original effects), 0.75, 0.626, 0.55, 0.5, 0.375, 0.25, 0.15,
0.1, 0.05. To each of 48 samples (randomly selected from
UPLC-MS data set) one of these 33 multivariate nutritional
effects (randomly selected) or their magnitudes were
added. In that way ten different data sets with different
magnitudes of superimposed nutritional effects were
obtained. Each of them consisted of 48 lipid proﬁles with
superimposed effects (the class of cases) and 48 lipid
proﬁles without superimposed effects (the class of
controls).
3.1.3.2 Exposure to a chemical pollutant Aldrin, an
isomer of hexachlorohexahydrodimethanonaphthalene,
C12H8Cl6 (Martin 1958; Younos and Weigmann 1988)i s
an organochlorine pesticide whose use is severely limited
in most countries and banned within the EU (http://www.
pesticides.gov.uk/approvals.asp?id=55). Despite the strict
regulation, the presence of this compound, as well of other
organochlorine pollutants, has been reported in the sera of
healthy subjects, suggesting that exposure to some orga-
nochlorine compounds is strongly related to environmental
contamination (Lino and Silveira 2006; Carren ˜o et al.
2007). (Lino and Silveira 2006) reported levels of Aldrin in
the blood of healthy subjects ranging from\5 to 400 lg/l
with an average concentration of 13 ± 42 lg/l.
The Aldrin spectrum was simulated for the average
concentration of this compound in blood (13 lg/L) and was
the linear combination of Lorentzian peaks as previously
described (Gu ¨nther and Gleason 1980; Cloarec et al. 2005).
Aldrin resonance positions where retrieved from the SDBS
online database (SDBSWeb: http://riodb01.ibase.aist.go.jp/
sdbs/ (National Institute of Advanced Industrial Science
and Technology, accessed in August 2010). A simulated
NMR spectrum of Aldrin contains 53 out of 420 data points
which are not equal to zero.
Exposure to this pollutant was introduced by superim-
posing the simulated NMR spectrum of Aldrin to the NMR
spectra of serum samples of healthy subjects from the
group of cases (randomly selected subjects: 30 out of 60 for
small NMR data sets and 100 out of 200 for large NMR
data sets). For the small NMR data sets the magnitudes of
pollutant levels were chosen to range from 0 (no exposure
to pollutant) to 50 times (0, 10, 15, 20, 25, 30, 35, 40, 45,
50) of the average observed concentration of Aldrin in
blood. For the large NMR data sets, the exposure intensity
ranged from 0 to 20 times (0, 2, 2.5, 5, 7.5, 10, 12.5, 15,
17.5, 20) of average concentration of Aldrin in blood.
3.2 Data analysis procedure and software
PLS-DA with a double cross validation procedure and four
different diagnostic statistics was used. This procedure was
applied M-times to each of UPLC-MS and NMR data sets
with superimposed nutritional or exposure effects (10
UPLC-MS data sets, 100 small NMR data sets and 100 large
NMR data sets). That resulted in M submodels for each data
set (M = 30 for each of UPLC-MS data set and M = 20 for
each of NMR data set). The performance of the PLS-DA
model of each data set was evaluated on the basis of means
of diagnostic statistics calculated across M submodels (see
Fig. 1b) and related to means of diagnostic statistics of
permutation tests using Eq. 7 to obtain P-value (for more
information see Supplementary Material). A number of
3000 permutation tests for each of UPLC-MS data sets and
2000 permutation tests for each of NMR data sets were
calculated using the same procedure as described above but
with permuted y. All analyses were done in Matlab 2010a
(The Mathworks Inc., Natick, Massachusetts, USA), using
Diagnostic statistics for PLS-DA models S9
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(Eigenvector Research Inc, Wenatchee WA). Permutation
tests have been performed on the LISA-SARA Dutch super-
computer (www.sara.nl).
4 Results and discussion
4.1 Statistical signiﬁcance of PLS-DA models vs.
magnitudes of superimposed effects and used
diagnostic statistics
Performance of PLS-DA model depends not only on the
data set used, thus differences between two classes (e.g.
magnitude of nutritional effects present in lipid proﬁles of
subjects from the class of cases). It can also depend on
values of diagnostic statistics used in optimization and
performance assessment of the PLS-DA model (see Fig. 1).
When differences between two classes are becoming very
small, the power of each of the diagnostic statistics can be
easily investigated in terms of their ability to provide a
statistically signiﬁcant measure of the discrimination
between the two classes. This is accomplished by super-
imposing known multivariate effects of decreasing mag-
nitude onto data of subjects from the class of cases and
calculating a series of PLS-DA models. In this series, a
single PLS-DA model is obtained for each of many data
sets with different magnitudes of superimposed effects and
one of four diagnostic statistics used in optimization and
performance assessment. The most powerful diagnostic
statistic is the one which provides a statistically signiﬁcant
PLS-DA model calculated for data with the smallest
superimposed effect.
4.1.1 UPLC-MS data sets with superimposed nutritional
effects
10 PLS-DA models were calculated for UPLC-MS data
sets with different magnitudes of superimposed effects and
each of four diagnostic statistics (Q
2, DQ
2, NMC or AU-
ROC) as described in Sect. 3.2. Each of 10 PLS-DA models
contained 30 submodels. The ranges of the 30 values of
each of the diagnostic statistics (obtained by 30 PLS-DA
submodels for each PLS-DA model, see Fig. 1b) are pre-
sented in Table 1. It should be notiﬁed that (i) the quality
of the PLS-DA models decreases when the magnitude of
the effects decrease: the values of Q
2, DQ
2 and AUROC
decrease and value of NMC increases and (ii) the range of
the values of the diagnostic statistics increases when the
magnitude of the effect decreases.
As already mentioned in the introduction section, the
values of diagnostic statistics do not alone indicate if
quality of model is good or bad and if differences between
two classes are statistically relevant or not. Statistical sig-
niﬁcance of diagnostic statistics values of any (sub)model
can be assessed by comparing them or their means (see
Fig. 1b) to values of their null reference distributions H0
obtained by permutation tests (see Sect. 2.2.6). A plot of
the P-values for each of the four diagnostic statistics as a
function of the effect magnitude (statistical signiﬁcance
proﬁle of each diagnostic statistics) is presented in Fig. 3a.
The signiﬁcance threshold a is usually set to 0.05 in the
majority of metabolomics applications. That means that P-
value smaller that 0.05 indicates that the null hypothesis H0
(no difference between the two classes) can be rejected and
observed difference between groups is assumed to be sta-
tistically signiﬁcant at a = 0.05. By inspection of Fig. 3ai t
Table 1 Performance of PLS-DA models of UPLC-MS data sets (96 samples and 101 metabolites) with different magnitudes of superimposed
effects
Effect magnitude/diagnostic statistics NMC AUROC DQ
2 Q
2
Min Max Min Max Min Max Min Max
1 30.4 32.8 0.7125 0.7484 0.0914 0.1258 -0.0091 0.0020
0.75 35.7 37.1 0.6387 0.6809 -0.0227 0.0199 -0.1845 -0.0965
0.625 38.4 40.0 0.5961 0.6361 -0.1046 -0.0474 -0.291 -0.1238
0.55 39.4 41.4 0.5731 0.6142 -0.1547 -0.074 -0.36 -0.1508
0.5 40.1 43.2 0.5532 0.5973 -0.1873 -0.0949 -0.4047 -0.1671
0.375 42.5 48.0 0.5053 0.5695 -0.2518 -0.1302 -0.5131 -0.1973
0.25 44.5 51.1 0.4742 0.5382 -0.3045 -0.1411 -0.5767 -0.1994
0.15 46.5 52.5 0.4608 0.5161 -0.3187 -0.1410 -0.6311 -0.2074
0.1 46.3 52.6 0.4571 0.5153 -0.3314 -0.1380 -0.6676 -0.1996
0.05 46.5 52.5 0.4573 0.5096 -0.3248 -0.1370 -0.6921 -0.2041
Performance of each model is assessed on the basis of 30 values obtained by 30 PLS-DA submodels. Minimum and maximum of 30 values of
each diagnostic statistics is presented. Better model performance is associated with higher values of AUROC, DQ
2 and Q
2 and with lower values
of NMC
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123appears that, given an effect magnitude, different diag-
nostic statistics give different P-values. To infer a statis-
tically signiﬁcant discrimination between the two classes
(P-value B 0.05), the effect magnitude need to be about 1,
0.85, 0.55 and 0.55 when Q
2, DQ
2, AUROC or NMC are
used, respectively. Models using NMC and AUROC clearly
outperform those based on Q
2 and DQ
2. NMC/AUROC
based models give signiﬁcant discrimination for an effect
magnitude (D effect C0.55 9 original effects) which is
half of that required for models based on Q
2 and DQ
2 (D
effect C1 9 original effects).
Interestingly, the DQ
2 and Q
2 P-values for very small
effects are not equal to 0.5. This fact may be related either
to inadequate number of PLS-DA submodels or to an un-
dersampling of the DQ
2 and Q
2 H0 distributions due to a
limited number of permutations. The number of PLS-DA
submodels (30 in our case) can be insufﬁcient to obtain a
representative mean value of the DQ
2 and Q
2 statistics.
That is highly probable when distribution of 30 values is
not symmetric. On the other hand, distributions of diag-
nostic statistics in permutation tests can also be essential in
estimating P-value. Distributions of permutation tests of y ˆi
and diagnostic statistics for models of UPLC-MS data set
with 0.75 9 effect were plotted in Supplementary Fig. 2.
Shapes of distributions of permutation tests of NMC and
AUROC are symmetric in contrary to DQ
2 and Q
2 distri-
butions which are left-side skewed. Distributions of per-
mutation tests of DQ
2 and Q
2 should be chi-square
distributions because they are distributions of sum of
squares (Eqs. 3 and 5) but there are not many values of
permutation tests in the right tail of those H0 distributions
when 3000 permutation tests are used. That makes an
accurate estimation of the P-value of diagnostic statistics
such as DQ
2 and Q
2 of the original models difﬁcult and
raises a question about the number of submodels and per-
mutation tests required to properly estimate P-values.
Another solution can be to apply resampling methods such
as bootstrap in combination with permutation testing.
4.1.2 NMR data sets with superimposed exposure effect
The multivariate effects added to the NMR data sets were
intended to mimic the exposure to a chemical pollutant.
The overall strategy of superimposing known multivariate
effects was an analogue to strategy applied to the UPLC-
MS data sets (see Sect. 4.1.1) but for each magnitude of
superimposed effects, 10 different data sets have been
randomly generated for a grand total of 100 data sets.
Therefore, the results presented for each magnitude of
superimposed effects refer to the average values over the
10 data sets. This extended strategy was chosen to take into
account the intrinsic variability when a data set is build by
sampling subjects from a larger population. The ranges of
the four diagnostic statistics for the different PLS-DA
models of small NMR data sets are given in Table 2.
Presented ranges show a similar behavior to that observed
for the UPLC-MS data sets (Table 1). Figure 3b presents
the P-values (averaged over the 10 data sets) as a function
of the effect magnitude (statistical signiﬁcance proﬁle of
each diagnostic statistics) for small NMR data sets. Here
also, NMC and AUROC outperform Q
2 and DQ
2 in term of
providing a statistically signiﬁcant discrimination between
classes. With the a = 0.05, signiﬁcant statistical discrimi-
nation is obtained for effect magnitude C20 for NMC/
AUROC optimized models. Magnitude C35 and 40 is
required for PLS-DA models optimized with DQ
2 and Q
2,
respectively. Again an effect magnitude ratio 1:2 is
observed as in the case of PLS-DA models of UPLC-MS
data sets. Similar results and conclusions also apply to the
large NMR data sets (see Supplementary Fig. 3).
Interestingly, the averaging over ten different data sets
leads to P-values &0.5 for the Q
2 and DQ
2 when no effect
Fig. 3 Statistical signiﬁcance proﬁles for PLS-DA models of UPLC-
MS data set (a) and NMR data set (b) when NMC, AUROC, Q
2 and
DQ
2 are used. Proﬁles show ability of each diagnostic statistics to
provide a statistically signiﬁcant measure of the discrimination
between two classes (P-value) as a function of the magnitude of the
multivariate effects added on the data (D effect)
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123is present, as it should be when no differences between
classes is expected. That was not the case for the UPLC-
MS data sets where only one data set is used for each effect
magnitude. There number of PLS-DA models and permu-
tation tests was not enough to properly estimate P-values.
4.2 Properties of PLS-DA models and diagnostic
statistics
In order to explain observed differences in the perfor-
mances of the models optimized and assessed by different
diagnostic statistics, other properties of obtained models
were evaluated further. Models complexity, distributions
and reproducibility of models predictions were studied.
4.2.1 Complexity of PLS-DA models in CV1
As illustrated in Fig. 1a, the Q
2, DQ
2, NMC, and AUROC
were used in the CV1 loop of the double cross-validation
procedure to optimize the number of latent variables of
each PLS-DA model generated in the CV1 loop. The use of
a particular diagnostic statistic in this place is a critical
point for differences in PLS-DA models performances
presented in Fig. 3. The type of diagnostic statistics can
strongly inﬂuence the model complexity, i.e. the number of
latent variables used in the model. That becomes even
more evident when complexity of models (ranging from 1
to 6 latent variables) is evaluated (Fig. 4a). It can be
observed that NMC/AUROC optimized models have usu-
ally more latent variables (#LVs: 4–6) than Q
2/DQ
2 opti-
mized models (#LV: 1–3). Moreover, this tendency is even
more prominent when differences between classes are
getting smaller and performance of models is getting worse
(Supplementary Fig. 4). This means that models selected
by Q
2 and DQ
2 are usually more simple and conservative
than those selected by NMC/AUROC. Taking into account
that NMC/AUROC selected models are more powerful in
detecting small differences between groups it can be con-
cluded that NMC/AUROC select models which use infor-
mation about these differences more extensively and for
that a higher number of latent variables is required. How-
ever, the higher number of latent variables makes inter-
pretation of results more difﬁcult and the number of latent
variables should generally be limited to a few latent vari-
ables. A maximum number of 6 latent variables used in this
study was chosen on the basis of previous analysis of
UPLC-MS and NMR data sets where 4–5 latent variables
were usually enough.
The complexity of the PLS-DA models has a direct
impact on model interpretation. PLS-DA models can be
used for biomarker discovery, for instance by looking at the
relative importance variables used in the PLS-DA model.
This can done by ranking the variables according the value
of their PLS regression coefﬁcients: the variable with the
largest (in absolute value) coefﬁcient gets rank 1, the
second one rank 2 and so on (Breitling, Armengaud et al.
2004)
In case of NMR data sets where simulated Aldrin
spectra was added, 53 biomarkers associated with exposure
to Aldrin (non-zero data points of Aldrin spectrum) are
expected to be found by the PLS-DA models. Figure 4b
shows the ranks of those 53 variables (for small NMR
dataset with magnitude of added effects equal 45) for six
PLS-DA models with different model complexity (from 1
to 6 latent variables). Each horizontal line presents a rank
of one of 53 biomarkers. Minimal rank is in this case 1 (the
Table 2 Performance of PLS-DA models of small NMR data sets (60 samples and 420 data points) with different magnitudes of superimposed
effects
Effect magnitude/diagnostic statistics NMC AUROC DQ
2 Q
2
Min Max Min Max Min Max Min Max
50 5.05 6.35 0.9473 0.9581 0.6176 0.6380 0.4766 0.4892
45 6.75 8.60 0.9367 0.9569 0.5694 0.6023 0.4193 0.4595
40 7.80 10.75 0.8928 0.9273 0.4751 0.5035 0.2662 0.2946
35 10.80 14.75 0.8366 0.8886 0.3245 0.4100 0.0756 0.1612
30 13.75 20.90 0.7329 0.8544 0.1276 0.3304 -0.1191 0.0698
25 17.75 24.55 0.6286 0.7741 -0.0133 0.1441 -0.2698 -0.2122
20 20.00 27.50 0.5513 0.7341 0.1220 0.0154 -0.3809 -0.3427
15 24.75 28.70 0.5221 0.6341 -0.1393 -0.1259 -0.6830 -0.4046
10 27.50 29.00 0.5145 0.5767 -0.2625 -0.1226 -0.6690 -0.2124
0 29.25 30.60 0.4988 0.5169 -0.2901 -0.1581 -0.7567 -0.2423
Performance of each model is assessed on the basis of 20 values obtained by 20 PLS-DA submodels. Minimum and maximum of 20 values of
each diagnostic statistics is presented. Better model performance is associated with higher values of AUROC, DQ
2 and Q
2 and with lower values
of NMC
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123most important variable out of 420 variables used in PLS-
DA model) and maximal rank is 420 (the least important
variable out of 420 variables used in PLS-DA model).
Statistical signiﬁcance of presented ranks was assessed by
10000 permutation tests and the corresponding P-values
were calculated as detailed in Sect. 2.2.6. Ranks of bio-
markers which obtained a P-value \0.05 are marked in
blue and those with P-value[0.05 are marked in red.
Figure 4b shows that the complexity of the model does
inﬂuence ranks of variables but most importantly inﬂu-
ences statistical signiﬁcance of variables with low ranks
(see variables with rank 1–30). It appears that simple
models built with fewer latent variables (LV from 1 to 3, as
those usually selected by Q
2/DQ
2 in CV1) fail in providing
statistical signiﬁcance for a great number of these low rank
variables, thus those variables will be omitted during bio-
marker selection. On the contrary, models built with more
latent variables (LV from 4 to 6, as those usually selected
by NMC/AUROC in CV1) are able to provide statistical
signiﬁcance to those most important variables. In this light
it appears that more complex models (selected by NMC/
AUROC) provide not only better discrimination of case and
control group but also are more informative and accurate in
term of biomarker discovery.
4.2.2 Distribution of predicted class membership vs. model
complexity in CV1
In CV1 the diagnostic statistics are calculated on the basis
of the predictions of categorical variable y ˆ for validation
set samples (Fig. 1a). Distributions of y ˆi obtained for all
samples of validation sets in CV1 for all 30 submodels of
the PLS-DA model of UPLC-MS data set with 0.75 9
effect were investigated. They are plotted for 1–6 latent
variables (#LV) in Fig. 5. In a case of ideal discrimination
of two classes, half of y ˆi should be equal to -1 (class of
controls) and other half to 1 (class of cases). This is hardly
true in metabolomics studies because of the inherent vari-
ation between the individuals within the same class. It was
also not the case in our data sets, where a majority of y ˆi has
Fig. 4 Complexity of the PLS-
DA models. a dependency of
the number of latent variables
(#LV) upon the diagnostic
statistics (NMC, AUROC, Q
2
and DQ
2) used in the model
optimization in CV1 of double
cross validation procedure for
UPLC-MS data set with
magnitude of superimposed
effects equal 0.75, b Ranks of
53 biomarkers (variables
associated with superimposed
multivariate effect) obtained by
PLS-DA models with different
complexity (1–6 latent
variables). PLS-DA models
were obtained for small NMR
data set with magnitude of
superimposed effects equal 45.
Ranks of biomarkers were
obtained over all 420 variables
in the data set according to the
corresponding absolute values
of their PLS regression
coefﬁcients. Ranks of
biomarkers statistically
signiﬁcant at a = 0.05 are
shown as dashed line and non-
signiﬁcant as regular line
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123values between -1 and 1. The distributions of y ˆi vary
between models with different number of latent variables.
The range of values of y ˆi increases and shape of distribution
is getting more ﬂat when #LV is increasing. Smaller
number of samples with y ˆi close to discrimination threshold
value (0 in this case) is observed for models with greater
complexity. That means smaller number of ambiguous
samples in the model and better model performance for
more complex models (usually selected by NMC and
AUROC).
When NMC and AUROC values are calculated it is only
important on which side of discrimination threshold value
is y ˆi (\or[0) but not its value itself. In this way the values
of y ˆi greater than 1 and lower than -1 do not inﬂuence
NMC and AUROC values more than the values of y ˆi
between -1 and 1 do. This is in contrary to Q
2 and DQ
2
which do not base on threshold value but on prediction
error between values of y ˆi and yi treating their values as
values of quantitative variable. In this case, the values of y ˆi
greater than 1 and lower than -1 do increase prediction
error and decrease values of Q
2 (DQ
2) prominently.
Complex PLS-DA models (#LV[3) have wider ranges of
y ˆi, greater prediction error and lower values of Q
2 and DQ
2.
That explains why when DQ
2 and Q
2 are used in the model
optimization in CV1 less complex models are selected.
When DQ
2 and Q
2 are used, the phrase ‘‘better safe than
sorry’’ is followed. Model with the smallest prediction
error e.g. the majority of y ˆi in a ‘‘safe’’ range -1t o1i s
selected and a number of samples with correctly predicted
class labels is not taken into account.
4.2.3 Reproducibility of predictions of PLS-DA models
in CV2
As detailed in Sect. 2.1.2 (see also Fig. 1b), for UPLC-MS
data set 30 different prediction vector y ˆ of the original class
membership vector y are generated by 30 submodels after
CV2 procedure. That assures that the ﬁnally considered y ˆ is
independent of random combinations of samples used in
double cross-validation procedure. Reproducibility of y ˆs
across different submodels can be easily employed in
describing PLS-DA models stability. For each study sam-
ple the variance across 30 prediction values y ˆi of different
submodels could be estimated and used in assessment of
PLS-DA model stability.
The variance of y ˆi across each of the 96 samples in the
UPLC-MS data set was calculated. Obtained variances
were averaged to give one mean variance representative for
predictions of all samples. This procedure was applied
separately to y ˆs obtained by the submodels with four dif-
ferent diagnostic statistics and 10 different effects super-
imposed. The results are graphically shown in Fig. 6. For
the largest effect magnitude (D effect = 1) UPLC-MS data
set all PLS-DA models show a signiﬁcant (at a = 0.05)
discrimination between the two classes. Then the mean
variance of y ˆ is &0.12 and it is independent on diagnostic
statistics used in model optimization. When the magnitude
of the effect is smaller than 0.55 and the discrimination
between the two classes is not signiﬁcant for all of pre-
sented models (Fig. 3a) and mean variance of y ˆ is depen-
dent on applied diagnostic statistics. Then, models
Fig. 5 Distributions of y ˆi (ypred) of validation set samples in CV1 vs. number of latent variables (#LV) in the PLS-DA model
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123optimized on the basis of NMC or AUROC statistics are
less reproducible than those optimized by Q
2 or DQ
2. The
reproducibility of y ˆ by the models optimized by DQ
2 and
Q
2 decreases when the magnitude of the effect increases.
This is an opposite behavior to this of y ˆ obtained by models
optimized with NMC and AUROC. The mean variance of y ˆ
for models optimized with Q
2 and DQ
2 is ca. two times
smaller than this of models with large signiﬁcant effects.
In conclusion, for small statistically insigniﬁcant effects
in data sets, Q
2/DQ
2 optimized models tend to give very
reproducible predictions what is in contrary to less repro-
ducible predictions NMC and AUROC optimized models.
That indicates that Q
2/DQ
2 optimized models are more
stable and conservative than NMC and AUROC optimized
models. This property can be associated with lower com-
plexity of those models described in Sects. 4.2.1 and 4.2.2.
5 Conclusion remarks
NMC, AUROC and DQ
2, Q
2 belong to two separate groups
of diagnostic statistics used in optimization and perfor-
mance assessment of PLS-DA models. Several theoretical
and practical differences between those diagnostic statistics
were presented in this paper.
PLS-DA models using NMC or AUROC as diagnostic
statistics are more powerful in detecting small differences
between two groups than models using DQ
2 or Q
2.T h i s
phenomenon is related to two factors: complexity of PLS-
DA models optimized during CV1 and distributions of
submodels and permutation tests used to calculate P-value.
During CV1, due to assumptions of (D)Q
2 diagnostics
statistics, models with lowest prediction error of class
membership are selected and these are not always the
models with best discrimination power. Additionally,
number of PLS-DA submodels as well as number of per-
mutation tests sufﬁcient for estimation P-values of NMC
and AUROC is usually not enough to properly estimate
P-values of DQ
2 or Q
2. Finally, PLS-DA models with
NMC or AUROC as diagnostic statistics are more accurate
in ﬁnding biomarkers responsible for two classes discrim-
ination with PLS-DA method.
Our recommendation for metabolomic studies with two
classes discrimination problem is to use NMC or AUROC
as diagnostic statistics of PLS-DA models.
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